Availability of Illegal Drugs During the Covid-19 Pandemic in Western Germany
Bibliographic Data
Background: In response to the COVID-19-pandemic, a lockdown was established in the middle of March 2020 by the German Federal Government resulting in drastic reduction of private and professional traveling in and out of Germany with a reduction of social contacts in public areas. Research Questions: We seek evidence on whether the lockdown has led to a reduced availability of illegal drugs and whether subjects with substance-related problems tried to cope with possible drug availability issues by increasingly obtaining drugs via the internet, replacing their preferred illegal drug with novel psychoactive substances, including new synthetic opioids (NSO), and/or by seeking drug treatment. Methods: A questionnaire was anonymously filled in by subjects with substance-related disorders, typically attending low-threshold settings, drug consumption facilities, and inpatient detoxification wards from a range of locations in the Western part of Germany. Participants had to both identify their main drug of abuse and to answer questions regarding its availability, price, quality, and routes of acquisition. Results: Data were obtained from 362 participants. The most frequent main substances of abuse were cannabis ( n = 109), heroin ( n = 103), and cocaine ( n = 75). A minority of participants reported decreased availability (8.4%), increased price (14.4%), or decreased quality (28.3%) of their main drug. About 81% reported no change in their drug consumption due to the COVID-19 pandemic and the lockdown. A shift to the use of novel psychoactive substances including NSO were reported only by single subjects. Only 1-2% of the participants obtained their main drug via the web. Discussion: Present findings may suggest that recent pandemic-related imposed restrictions may have not been able to substantially influence either acquisition or consumption of drugs within the context of polydrug users (including opiates) attending a range of addiction services in Germany
Cannabinoid · Cannabis · Consumption (sociology · Coronavirus disease 2019 (COVID-19 · Disease · Drug · Environmental health · Government (linguistics · Heroin · Pandemic · Psychiatry · Psychoactive drug · Substance abuse · Synthetic cannabinoids · COVID-19 and Mental Health · HIV, Drug Use, Sexual Risk · Medicine · Opioid Use Disorder Treatment
Deaths of despair before and during the Covid-19 pandemic
Consumption patterns before and during the Covid-19 pandemic among patients admitted to inpatient drug detoxification treatment
Impulsivity as a Risk Factor for Addictive Disorder Severity during the Covid-19 Lockdown
The Scale of Intoxications with New Psychoactive Substances over the Period 2014–2020—Characteristics of the Trends and Impacts of the Covid-19 Pandemic on the Example of Łódź Province, Poland
Spatiotemporal Mapping of Online Interest in Cannabis and Popular Psychedelics before and during the Covid-19 Pandemic in Poland
The Drug Sellers Were Better Organized than the Government”
Associations Between Drug Use and Mental Health Service Utilization Among US Adults
Restrictive measures and substance use reporting
Negotiating an Illicit Economy in the Time of Covid-19
| Citations per year | 2.25 |
|---|---|
| Citation span | 2022 - 2026 (5) |
| Highly cited | No |